SIOC English
有机化学
高级检索

有机化学 >

2018 , Vol. 38 >Issue 4: 919 - 925

DOI: https://doi.org/10.6023/cjoc201711016

研究论文

薯蓣皂苷元抗肿瘤衍生物的合成及其生物活性的研究

  • 罗卓玛 ,
  • 胡越高 ,
  • 王璐红 ,
  • 尹祥健 ,
  • 马晓东 ,
  • 杨鸿均 ,
  • 赵志刚
展开
  • a 西南民族大学化学与环境保护工程学院 成都 610041;
    b 大连医科大学药学院 大连 116044;
    c 四川川大华西药业股份有限公司 成都 610014

收稿日期: 2017-11-08

  修回日期: 2018-01-05

  网络出版日期: 2018-01-18

基金资助

国家自然科学基金（No.21602083）、西南民族大学研究生创新型科研（No.CX2016SZ045）、四川省教育厅研究（No.15ZB0487）资助项目.

收起

Study on the Synthesis and Bioactivity of Diosgenin Antitumor Derivatives

  • Luo Zhuoma ,
  • Hu Yuegao ,
  • Wang Luhong ,
  • Yin Xiangjian ,
  • Ma Xiaodong ,
  • Yang Hongjun ,
  • Zhao Zhigang
Expand
  • a College of Chemistry and Environmental Protection Engineering, Southwest University for Nationalities, Chengdu 610041;
    b College of Pharmacy, Dalian Medical University, Dalian 116044;
    c Sichuan Chuanda Huaxi Pharmaceutical Co., Ltd., Chengdu 610014

Received date: 2017-11-08

  Revised date: 2018-01-05

  Online published: 2018-01-18

Supported by

Project supported by the National Natural Science Foundation of China (No. 21602083), the Southwest University for Nationalities Graduate Student Innovative Project (No. CX2016SZ045), and the Sichuan Provincial Department of Education Research Project (No. 15ZB0487).

Fold

摘要

以薯蓣皂苷元为先导物，设计并合成了9个新的薯蓣皂苷元含氮衍生物，其结构经过1H NMR，13C NMR，IR和HRMS鉴定.所有衍生物采用噻唑蓝（MTT）法进行抗肿瘤活性（A549，A431，H1975，HCT-116，Aspc-1，Ramos）的测定以及细胞毒性（HBE，LO-2）的研究.研究结果表明，大部分薯蓣皂苷元衍生物具有显著的抗肿瘤活性和低细胞毒性.

关键词： 薯蓣皂苷元; 衍生物; 抗肿瘤活性; 酰胺

本文引用格式

罗卓玛 , 胡越高 , 王璐红 , 尹祥健 , 马晓东 , 杨鸿均 , 赵志刚 . 薯蓣皂苷元抗肿瘤衍生物的合成及其生物活性的研究[J]. 有机化学, 2018 , 38(4) : 919 -925 . DOI: 10.6023/cjoc201711016

Abstract

Nine novel diosgenin derivatives were designed and synthesized by using diosgenin as a precursor. Their structures were identified by 1H NMR, 13C NMR, IR and HRMS. Antitumor activity (A549, A431, H1975, HCT-116, Aspc-1, Ramos) and cytotoxicity (HBE, LO-2) were measured for all derivatives using thiazolyl blue tetrazolium bromide (MTT). The results show that most diosgenin derivatives have significant anti-tumor activity and low cytotoxicity.

Key words： diosgenin; derivative; antitumor activity; amide

参考文献

[1] Tang, S. R.; Yang, R. T.; Pan, F. S. J. Plant. Resour. Environ. 2007, 16, 64(in Chinese). (唐世荣, 杨如同, 潘福生, 植物资源与环境学报, 2007, 16, 64.)
[2] Sun, Q.; Ju, Y.; Zhao, Y. F. Chin. Tradit. Herb. Drugs 2002, 33, 276(in Chinese). (孙麒, 巨勇, 赵玉芬, 中草药, 2002, 33, 276.)
[3] Mattew, J. K.; Mary, L. T.; Jing, Z. H. Bioorg. Med. Chem. 2008, 16, 3209.
[4] Liu, C.; Wang, Z. Z.; Zheng, W. West China J. Pharm. Sci. 2009, 24, 483(in Chinese). (刘超, 王珍珍, 郑微, 华西药学杂志, 2009, 24, 483.)
[5] Yue, L.; Chen, L.; Kou, J. P. Chin. J. Clin. Pharmacol. Ther. 2010, 15, 233(in Chinese). (岳蕾, 陈玲, 寇俊萍, 中国临床药理学与治疗学, 2010, 15, 233.)
[6] Zeng, C. L.; Gen, Q.; Wu, Y. K. West China J. Pharm. Sci. 2011, 26, 423(in Chinese). (曾春玲, 耿倩, 吴亚克, 华西药学杂志, 2011, 26, 423.)
[7] Wang, B.; Chun, J.; Liu, Y. Org. Biomol. Chem. 2012, 10, 8822.
[8] Wang, Y.; Pan, K.; Chang, T. J. Nat. Prod. 2011, 74, 580.
[9] Yayoi, T.; Naoko, K.; Akinori, H. Steroids 2009, 74, 504.
[10] Wang, L. J.; Wang, Y.; Chen, S. W. China J. Chin. Mater. Med. 2002, 27, 777(in Chinese). (王丽娟, 王岩, 陈声武, 中国中药杂志, 2002, 27, 777.)
[11] Cecile, C.; Bertrand, L. Cell Res. 2004, 14, 188.
[12] Huo, R.; Zhou, Q. L.; Wang, B. X. Acta Pharmacol. Sin. 2004, 25, 1077.
[13] Fu, W. W.; Wu, Y, K.; Fan, J. Z. West China J. Pharm. Sci. 2010, 25, 658(in Chinese). (傅微微, 吴亚克, 范举正, 华西药学杂志, 2010, 25, 658.)
[14] Liao, P. F.; Dong, J. H.; Fan, J. Z. West China J. Pharm. Sci. 2013, 28, 364(in Chinese). (廖鹏飞, 董江红, 范举正, 华西药学杂志, 2013, 28, 364.)
[15] Wu, Y. K.; He, G.; Fu, W. W. West China J. Pharm. Sci. 2012, 27, 22(in Chinese). (吴亚克, 何谷, 傅微微, 华西药学杂志, 2012, 27, 22.)
[16] Dong, J. H.; He, G.; Wu, Y. K. Chin. Pharmacol. Bull. 2012, 47, 1407(in Chinese). (董江红, 何谷, 吴亚克, 中国药学杂志, 2012, 47, 1407.)
[17] Zhang, H. B.; Yang, X. D.; Qin, C.; Liu, Y. L.; Li, L.; Liu, J. P. CN 1876672, 2006.
[18] Zhang, R.; Guo, X. R.; He, Y.; Huang, W. West China J. Pharm. Sci. 2013, 28, 229(in Chinese). (张瑞, 郭秀蓉, 何杨, 黄文, 华西药学杂志, 2013, 28, 229.)
[19] Ding, X. Y.; He, G.; Jiang, H. P. West China J. Pharm. Sci. 2012, 46, 539(in Chinese). (丁晓勇, 何谷, 蒋红平, 药学学报, 2012, 46, 539.)
[20] Geng, Q.; Zeng, C. L.; Fu, W. W. West China J. Pharm. Sci. 2009, 24, 475(in Chinese). (耿倩, 曾春玲, 傅微微, 华西药学杂志, 2009, 24, 475.)
[21] Lu, L. H.; Wu, D. S.; Peng, L. F.; Xu, M.; Lu, X. P.; Mei, S. X. J. Yunnan Univ. (Nat. Sci. Ed.) 2015, 37, 415(in Chinese). (陆礼和, 吴德松, 彭玲芳, 徐明, 陆雪萍, 梅双喜, 云南大学学报(自然科学版), 2015, 37, 415.)
[22] Zheng, W.; Jiang, H. P.; Wu, Y. K. West China J. Pharm. Sci. 2011, 26, 107(in Chinese). (郑微, 蒋红平, 吴亚克, 华西药学杂志, 2011, 26, 107.)
[23] Fu, X. L.; Han, Y. M.; Zhang, S. J. Drugs Clin. 2011, 26, 46(in Chinese). (付晓丽, 韩英梅, 张士俊, 现代药物与临床, 2011, 26, 46.)
[24] Fan, L. H.; Cui, J. G.; Gan, C. F.; Su, S. Y. Chem. Res. Appl. 2012, 24, 8(in Chinese). (范良华, 崔建国, 甘春芳, 苏绍烊, 化学研究与应用, 2012, 24, 8.)
[25] Fujii, N.; Mallari, J. P.; Hansell, E. J. Bioorg. Med. Chem. Lett. 2005, 15, 121.
[26] Renard, D.; Perruchon, J.; Giera, M. Bioorg. Med. Chem. 2009, 17, 8123.
[27] Stulov, S. V.; Zavialova, M. G.; Mehtiev, A. R. Bioorg. Med. Chem. Lett. 2010, 20, 5495.
[28] Handratta, V. D.; Vasaitis, T. S.; Njar, V. C. O. J. Med. Chem. 2005, 48, 2972.
[29] Banday, A. H.; Mir, B. P.; Lone, I. H. Steroids 2010, 75, 805.
[30] Xie, W. G.; Peng, H. R.; Zalkow, L. H. Bioorg. Med. Chem. 2000, 8, 699.
[31] Burbiel, J.; Bracher, F. Steroids 2003, 68, 587.
[32] Lian, P.; Li, L. L.; Geng, C. R.; Zhen, X. C.; Fu, W. J. Chem. Inf. Model. 2015, 55, 1616.
[33] Wang, Q. Q. M.S. Thesis, Anhui Medical University, Hefei, 2016(in Chinese). (王欠欠, 硕士论文, 安徽医科大学, 合肥, 2016.)
[34] Ai, Y. S.; Liu, L. Q.; Xu, C. H.; Chen, H. T.; Sun, X. X. Her. Med. 2015, 24, 626(in Chinese). (艾又生, 刘力强, 徐楚鸿, 陈华庭, 孙小香, 医药导报, 2015, 24, 626.)

Options
文章导航

/

〈 〉